Description
FORMA FARMACÉUTICA: 30 CAPSULAS
DOSIS: 5 ML
Riesgo de acidosis láctica asociado a metformina
PRINCIPIO ACTIVO: SUBSALICILATO DE BISMUTO
DERFINACMA.1%CAJAC/TUBOC/30G. EQUIPO Y BOTIQUIN FORMA FARMACÉUTICA: 30 CAPSULASPRINCIPIO ACTIVO: BUTENAFINA CLORHIDRATO 0. 01 DOSIS: 30 G FORMA FARMACUTICA: 1 CREMA PRESENTACIN: 1 TUBO
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
